Minerva Neurosciences Announces Positive Top Line Results From Phase Ib Clinical Trial in Major Depressive Disorder With MIN-202
11 mars 2016 08h30 HE
|
Minerva Neurosciences, Inc
Treatment with selective orexin-2 receptor antagonist observed to be well tolerated and to improve symptoms of depression, independent from its effect on sleep WALTHAM, Mass., March 11, 2016 ...
Fact Sheet: Managing Treatment For Individuals With Major Depressive Disorder (MDD) - Top 10 New Resources On PsychU
16 mars 2015 14h36 HE
|
PsychU
GETTYSBURG, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Fact Sheet | New articles, resources, and presentations related to managing treatment for individuals with major depressive disorder (MDD) now...
Neuronetics, Inc. Raises $30 Million in Series E Financing
16 mai 2011 08h30 HE
|
Neuronetics
MALVERN, PA--(Marketwire - May 16, 2011) - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® System for the treatment of major depression*, announced today...
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
15 mai 2011 19h00 HE
|
Neuronetics
HONOLULU, HI--(Marketwire - May 15, 2011) - Results of a Neuronetics-sponsored, multisite observational study of patients with major depressive disorder (MDD) treated with Neuronetics' NeuroStar...
Neuronetics Receives TiE50 Award for Technology Entrepreneurship
09 mai 2011 08h30 HE
|
Neuronetics
MALVERN, PA--(Marketwire - May 9, 2011) - Neuronetics, Inc., maker of the NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy® System, has been selected by TiE Silicon Valley as a 2011 recipient...
New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
14 avr. 2011 13h30 HE
|
Neuronetics
HONOLULU, HI--(Marketwire - Apr 14, 2011) - In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with...
Neuronetics Appoints Vice President of Health Policy and Government Relations
02 mars 2011 08h00 HE
|
Neuronetics
MALVERN, PA--(Marketwire - March 2, 2011) - Neuronetics, Inc. today announced that Mary Hailey, an industry executive with more than 25 years of experience in designing and implementing healthcare...
NeuroStar TMS Therapy Continues to Grow as a Standard of Care for Patients With Depression
10 janv. 2011 13h13 HE
|
Neuronetics
MALVERN, PA--(Marketwire - January 10, 2011) - Neuronetics, Inc., is pleased to announce that effective January 1, 2011, new Category I CPT® codes are available for billing the medical...